Carlos Cara

555 total citations
21 papers, 419 citations indexed

About

Carlos Cara is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Genetics. According to data from OpenAlex, Carlos Cara has authored 21 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 7 papers in Epidemiology and 6 papers in Genetics. Recurrent topics in Carlos Cara's work include Acute Lymphoblastic Leukemia research (11 papers), Microscopic Colitis (7 papers) and Inflammatory Bowel Disease (6 papers). Carlos Cara is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Microscopic Colitis (7 papers) and Inflammatory Bowel Disease (6 papers). Carlos Cara collaborates with scholars based in Spain, Belgium and Brazil. Carlos Cara's co-authors include Javier P. Gisbert, Luis G. Guijarro, Marta Luna, José Marı́a Pajares, Luı́s Rodrigo, José Luís Mate, Fernando Gomollón, Yago González‐Lama, S. Ramiro and Alejandro Balsa and has published in prestigious journals such as Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and The American Journal of Gastroenterology.

In The Last Decade

Carlos Cara

20 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Cara Spain 11 180 141 106 84 68 21 419
Andrew Y. F. Li Yim Netherlands 11 175 1.0× 172 1.2× 65 0.6× 168 2.0× 101 1.5× 27 544
Malin Lindqvist Sweden 8 181 1.0× 43 0.3× 28 0.3× 100 1.2× 48 0.7× 9 424
Marianne Wigger Germany 11 61 0.3× 26 0.2× 97 0.9× 81 1.0× 63 0.9× 24 505
Guanping Dong China 13 66 0.4× 136 1.0× 91 0.9× 150 1.8× 29 0.4× 51 471
Inbar Ben‐Shachar Israel 14 63 0.3× 63 0.4× 104 1.0× 120 1.4× 30 0.4× 25 657
Ikuya Usami Japan 12 91 0.5× 31 0.2× 33 0.3× 137 1.6× 49 0.7× 52 380
Oldřich Pozler Czechia 11 33 0.2× 72 0.5× 72 0.7× 24 0.3× 60 0.9× 19 335
Daphna Marom Israel 11 77 0.4× 65 0.5× 113 1.1× 227 2.7× 19 0.3× 26 510
Hilmi Apak Türkiye 14 94 0.5× 19 0.1× 57 0.5× 96 1.1× 52 0.8× 44 445
Marianne Rodrigues Fernandes Brazil 12 69 0.4× 78 0.6× 25 0.2× 149 1.8× 27 0.4× 63 391

Countries citing papers authored by Carlos Cara

Since Specialization
Citations

This map shows the geographic impact of Carlos Cara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Cara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Cara more than expected).

Fields of papers citing papers by Carlos Cara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Cara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Cara. The network helps show where Carlos Cara may publish in the future.

Co-authorship network of co-authors of Carlos Cara

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Cara. A scholar is included among the top collaborators of Carlos Cara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Cara. Carlos Cara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ferrari, Teresa Cristina Abreu, et al.. (2020). Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease. Gastroenterología y Hepatología. 44(2). 87–95. 5 indexed citations
3.
Cara, Carlos, et al.. (2018). Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis. Digestive Diseases and Sciences. 63(3). 731–737. 20 indexed citations
4.
Levy, Roger A., et al.. (2016). Biology of Anti-TNF Agents in Immune-Mediated Inflammatory Diseases: Therapeutic Implications. Immunotherapy. 8(12). 1427–1436. 15 indexed citations
5.
Taxonera, Carlos, et al.. (2015). Tu1113 Endoscopic and Histologic Remission Correlation With Biomarkers in UC Patients Treated With Adalimumab. Gastroenterology. 148(4). S–791. 3 indexed citations
6.
7.
Falip, Mercè, Xavier Salas‐Puig, & Carlos Cara. (2013). Causes of CNS Inflammation and Potential Targets for Anticonvulsants. CNS Drugs. 27(8). 611–623. 20 indexed citations
8.
García‐Arias, Miriam, Dora Pascual‐Salcedo, S. Ramiro, et al.. (2013). Calprotectin in Rheumatoid Arthritis. Molecular Diagnosis & Therapy. 17(1). 49–56. 60 indexed citations
9.
Domènech, Eugeni, José Luis Cabriada, Antonio Bernal, Carlos Cara, & M A Gassull. (2008). Certolizumab Pegol Therapy in a Patient with Crohnʼs Disease with Previous Loss of Response to 2 Anti-TNF Agents. The American Journal of Gastroenterology. 103. S429–S429. 1 indexed citations
10.
Gisbert, Javier P., Fernando Gomollón, Carlos Cara, et al.. (2007). Thiopurine Methyltransferase Activity in Spain: A Study of 14,545 Patients. Digestive Diseases and Sciences. 52(5). 1262–1269. 69 indexed citations
11.
Gisbert, Javier P., et al.. (2007). Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.. PubMed. 53(69). 399–404. 27 indexed citations
12.
Gisbert, Javier P., et al.. (2006). Thiopurine Methyltransferase (TPMT) Activity and Adverse Effects of Azathioprine in Inflammatory Bowel Disease: Long-Term Follow-Up Study of 394 Patients. The American Journal of Gastroenterology. 101(12). 2769–2776. 75 indexed citations
13.
Gisbert, Javier P., Fernando Gomollón, Carlos Cara, et al.. (2005). Actividad de la tiopurina metiltransferasa en la enfermedad inflamatoria intestinal. Un estudio en 7.046 pacientes españoles. Medicina Clínica. 125(8). 281–285. 6 indexed citations
14.
Escribano, Óscar, Carlos Cara, Michele Lorusso, et al.. (2004). Azathioprine Acts upon Rat Hepatocyte Mitochondria and Stress-Activated Protein Kinases Leading to Necrosis: Protective Role of N-Acetyl-L-cysteine. Journal of Pharmacology and Experimental Therapeutics. 311(2). 668–676. 44 indexed citations
15.
Gisbert, Javier P., et al.. (2003). Actividad de la tiopurina metiltransferasa en pacientes con hepatitis autoinmune. Medicina Clínica. 121(13). 481–484. 1 indexed citations
16.
Gisbert, Javier P., et al.. (2003). Actividad de la tiopurina metiltransferasa en pacientes con hepatitis autoinmune. Medicina Clínica. 121(13). 481–484. 4 indexed citations
17.
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Y. F. Li Yim Breakdown of academic impact, for papers by Malin Lindqvist Breakdown of academic impact, for papers by Marianne Wigger Breakdown of academic impact, for papers by Guanping Dong Breakdown of academic impact, for papers by Inbar Ben‐Shachar Breakdown of academic impact, for papers by Ikuya Usami Breakdown of academic impact, for papers by Oldřich Pozler Breakdown of academic impact, for papers by Daphna Marom Breakdown of academic impact, for papers by Hilmi Apak Breakdown of academic impact, for papers by Marianne Rodrigues Fernandes
Rankless by CCL
2026